Cargando…
CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity
Dendritic cells (DCs), as professional antigen-presenting cells are essential for the initial activation of adaptive antitumor immunity. CD1d is considered to present phospholipid and glycosphingolipid antigens to NKT cells. However, it is currently unknown whether CD1d expression on DCs is capable...
Autores principales: | Li, Yifan, Zhao, Chujun, Liu, Jiajing, Lu, Zhou, Lu, Mingfang, Gu, Jie, Liu, Ronghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448128/ https://www.ncbi.nlm.nih.gov/pubmed/30864713 http://dx.doi.org/10.3892/or.2019.7037 |
Ejemplares similares
-
Intestinal CD11b(+) B Cells Ameliorate Colitis by Secreting Immunoglobulin A
por: Fu, Ying, et al.
Publicado: (2021) -
The Closely Related CD103(+) Dendritic Cells (DCs) and Lymphoid-Resident CD8(+) DCs Differ in Their Inflammatory Functions
por: Jiao, Zhijun, et al.
Publicado: (2014) -
CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma
por: Li, Zhou, et al.
Publicado: (2022) -
Enhanced Antitumor Immunity in Mice Deficient in CD69
por: Esplugues, Enric, et al.
Publicado: (2003) -
Co‐immunization with L‐Myc enhances CD8(+) or CD103(+) DCs mediated tumor‐specific multi‐functional CD8(+) T cell responses
por: Chai, Dafei, et al.
Publicado: (2021)